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SUMMARY 
Thirty patients of affective disorder who were on lithium for a year and thirty patients on antidepressant 
were studied in detail for renal functions. Our observation is that lithium therapy does not lead to any deterioration 
in kidney functions. The results are discussed. 
Since the discovery by Cade (1949), li-
thium has gained more and more popular-
ity as a therapeutic and prophylatic agent 
for affective disorder. Of late, attention has 
been drawn towards it's various side effects 
during long term therapy, especially those 
which affect the kidneys. Lithium is totally 
eliminated through the kidneys and is con-
centrated in renal medulla hence there is a 
high risk for the occurrence of renal patho-
logy. Amongst the various renal effects of 
lithium, some are known to be reversible, 
while others are speculated to be irrever-
sible. Amongst the reversible changes are 
natreuresis (Cox and Singer 1981), im-
paired urinary acidification (Cox and Sin-
ger 1981), and polyuria and polydipsia me-
diated by several mechanisms of which un-
responsiveness of renal tubules to central 
AD H seems to be an important one (Jack-
son et al. 1980). The latter effect, however, 
is reported to be persistent and irreversible 
by some investigators (Robin et al. 1979, 
Bucht and Wahlin 1980). This impairment 
has also been reported due to other psycho-
tropic agents (Wahlin et al. 1980) as well as 
due to the illness itself (Miller et al. 1970). 
Histopathological studies have demons-
trated a marked damage to distal convolut-
ed tubules (Patfield 1975), interstitial fi-
brosis and interstitial nephritis (Hestbech et 
al. 1977, Burrows et al. 1978, Rafaelson et 
al. 1978) and necrosis of distal nephrons 
(Burrows et al. 1978). Hestbech and asso-
ciates (1977) also reported impaired renal 
concentrating ability and a rise in serum 
creatinine. Later on controlled studies did 
not reveal any significant difference 
between lithium treated and non-lithiurn 
treated patients of affective disorders as re-
gards renal functions (Hullin et al. 1979, 
Coppen et al. 1980). Contrary findings 
have been reported by Albrecht and asso-
ciates (1980). Hence the subject of lithium 
induced renal changes is still controversial 
and reports are far from conclusive. The 
present controlled study aims to clarify this 
issue by studying the possible association 
between lithium therapy and renal damage. 
Material and Methods 
Sample: 
The sample was chosen from patients 
attending lithium clinic of the depar-
tment of Psychiatry, K. G's. Medical Col-
lege, Lucknow. It consisted of two groups 
of patients. Group-I consisted of patients 
satisfying the following inclusion 
criteria: 
1. Scientist, Central Drug Research Institute, Lucknow. 
2. Lecturer, Department of Psychiatry, K. G's. Medical College, Lucknow. 
3. Director, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow. 68  LITHIUM AND RENAL FUNCTIONS 
a). Age between 17-60 years, any sex 
b). Diagnosed as MUP unipolar or bipolar, 
currently euthymic according to ICD-9 
criteria. 
c). No h/o renal disease. 
d). On regular lithium therapy for not 
more than one year and at least for two 
months. 
e). If on concomitant drug administra-
tion - only neuroleptics or antidepres-
sants. 
Group - II consisted of age and sex 
matched patients satisfying criteria a, b, and 
c as above, having no history of treatment 
with lithium, though receiving either neu-
roleptics or antidepressants for 2 to 6 
months. 
Procedure: 
All the included patients were subjected 
to a detailed mental status examination and 
their psychiatric history was recorded. A 
thorough general and systematic examina-
tion was done in each case. Various socio 
demographic variables were recorded and 
each patient was subjected to following 
investigations: 
1) Weight charting. 
2) Serum lithium estimation and record-
ing of lithium dosage. 
3) 24 hour urine output. 
4) Specific gravity after 12 hours fasting. 
5) Urinary pH (using pH meter). 
6) Urinary proteins, and urinary creatin-
ine (Alkaline picrate method). 
7) Urine sugar (Benedict's test). 
8) Microscopic examination of urine. 
9) Urinary ADH (antidiuretic hormone) 
(Method of Noble et al. 1950). 
11) Serum electrolytes Na
+, K
+, Li
+ 
and Cl (using flame photometer, mer-
curic nitrate method). 
12) Serum uric acid (phosphotungustic 
acid method). 
13) Serum creatinine (colorimetric me-
thod) and creatinine clearance test (as 
an index for glomerular filteration 
rate). 
Standardisation of all the biochemical 
investigations was done at our laboratory 
and the Central Drug Research Institute, 
Lucknow. 
Results 
Experimental group consisted of 30 pa-
tients of affective disorder, 4 patients were 
of MDP unipolar and 26 had MDP bipo-
lar. Control group (Group C) consisted of 
total 25 patients, 4 of MDP unipolar and 
21 MDP bipolar. There were 3 females 
each in both the groups, 27 males in experi-
mental group and 22 males in control 
group. There was no significant difference 
between the two groups either in terms of 
age distribution or religion. Amongst the 
experimental group 16 patients had re-
ceived lithium for 2 to 6 months (Group A) 
and 14 patients had received lithium for 6 
months to one year (Group B). 
Amongst the two groups having 
polyuria (defined as 24 hours urine output 
more than 3 litres), there was no signific-
ant difference between the experimental 
and control group although 3 patients in 
each group A and C had polyuria. There 
was no significant difference between the 
two groups in percentage of patients 
having impaired urinary concentrating 
ability as tested by 12 hours dehydration 
test. 
The two groups of experimental pa-
tients did not have significantly different 
levels of urinary lithium, sodium, potassium 
and chloride ions. Patients having re-N. SETHI ET AL. 
Table 1 
Urinary Values 
Mean ± S. D.  Range 
(a) 
(b) 
Urinary Potassium (in Meq/Day, Normal =25 -
Group A 28.11 ±15.61 
Group B 34.91+12.25 
Group ^ 66.53± 18.7 
125 Meq/Day) 
A Vs B 
A Vs ^ 
= 0.96; d.f.< 
= 2.97 ; d.f. • 
28; N. S. 
39; P<0.01 
Urinary Chloride (in Meq/Day) 
Group A 74.12 ±19.1. 
Group B 82.63±38.5 
Groups 156.94 ±47.7 
A Vs B 
A Vs ^ 
= 1.52; d.f.= 
= 2.10; d.L-
28; N. S. 
39; P<0.05 
2.1-127.6 
19.88-121.1 
36.8 - 90.0 
76-230 
49.3-251.25 
39- 113 
(There were no differences between the groups as regards urine volume, specific gravity, urinary lithium, urinary 
sodium, urine creatinine, urine ADH and PH) 
Table 2 
Serum Values 
Mean ± S. D.  Range 
Serum Uric acid (Normal 3-7 mg/100 ml) 
Group A 
Group B 
Group ^ 
A Vs B 
AVSL 
4.57 ± 0.71 
4.54 ± 0.89 
5.4 ± 0.58 
t, = 0.09; d. f. = 28; N. S. 
t2 = 3.91; d. f. = 39; P < 0.001 
3.3 - 5.8 
3.25 - 6.2 
4.0 - 6.2 
ceived lithium had significantly lower level of 
urinary potassium (p < .01) and urinary chlo-
ride ions (p < 0.05) as compared to controls, 
but the values of all the patients were within 
normal range of variation (Table 1). There 
was no significant difference in the urinary 
creatinine and ADH levels between the ex-
perimental and control groups. 
The experimental and control group did 
not differ from each other in terms of urine 
pH. 
Mean serum lithium of the patients tak-
ing lithium for 2 to 6 months was 0.53 
mEq/L and that of the patients taking li-
thium for 6 months to one year was 0.56 
mEq/L. There was no significant differ-
ence between the two groups. There was 
no significant difference in levels of serum 
electrolytes (Na , K and Cl ) creatinine 
and uric acid between the two groups of ex-
perimental patients amongst themselves 
and between experimental and control 
groups. 
Glomerular filteration rate as inferred 
by creatinine clearance test was not signifi-
cantly different between the two groups. 
Discussion 
This is a controlled study of 30 patients of 
affective disorder, who had been on lithium 
for a period ranging between 2 months to one 
year, and 25 patients of affective disorder 
who had not received lithium. 70  LITHIUM AND RENAL FUNCTIONS 
Measurement of total 24 hour urine vo-
lume reveals that almost equal number of 
patients with lithium and without lithium 
had polyuria (volume exceeding 3 litres), 
thus our study does not indicate that po-
lyuria is a side-effect of lithium adminis-
tration. 
Gelenberg (1980) suggested that speci-
fic gravity measurement can be used to 
measure renal concentrating ability. 
Various methods like 12 hours dehydration 
test, 3-4 hours dehydration test with 
DDAVP, 26 hours dehydration test etc. 
have been used by different workers. In the 
present study, specific gravity of 1016 or 
less was taken as the measure or impaired 
concentrating ability. Only one patient 
each in the 2-6 months group, as well as in 
the control (non-lithium treated) group 
showed impairment in concentrating abil-
ity, a finding in conformity with that of 
Coppen et al. (1980), Vestergaard and Am-
disen (1981) that lithium does not have ef-
fect on renal functions. Animal studies have 
reported a decreased ability to lower urin-
ary pH in response to acid loading (Roscoe 
et al. 1976, Nascimento et al. 1977). There 
have been similar but inconsistent reports 
in experiments on human subjects (Miller 
et al. 1970). Our study does not support 
these previous observations and conforms 
to the observations of Venkoba Rao and as-
sociates (1979). 
None of the patients presented with 
metabolic acidosis as is evidenced by 
normal serum and urinary electrolytes le-
vels. Patients on lithium therapy had signi-
ficantly lower urinary potassium and 
chloride as compared to patients without 
lithium, but the values of all the patients 
were within normal range of variation. The 
significance of this difference is therefore 
not much. This variation could have been 
due to difference in dietary intake. 
Serum creatinine has been shown to the 
increased in patients on lithium (Vester-
gaard et al. 1979, Hansen et al. 1979). In the 
present study patients on lithium for 2 to 6 
months had the same levels of GFR (as evi-
denced by serum creatinine and creatinine 
clearance) as those of patients on lithium 
for 6 months to 1 year and patients without 
lithium. Hullin and associates (1979) and 
Coppen et al. (1980) also observed similar 
results. Other uncontrolled studies (Ven-
koba Rao et al. 1979, Grof et al 1980, Al-
brecht et al. 1980) have also observed nor-
mal GFR in lithium treated patients. Pre 
existing renal disease and mechanical and 
procedural difference, vitiate the results of 
several uncontrolled studies in this regard. 
Serial estimations may be the answer to this 
issue. Vestergaard and Amdisen (1981) in a 
followup study of 237 patients in long term 
treatment observed that neither the pa-
tients who continued nor the patients who 
had discontinued lithium showed any dete-
rioration of glomerular filteration rate as as-
sessed through determination of the 24 
hour creatine clearance and the serum crea-
tinine concentration. Apart from mechani-
cal errors, such differences could be due to 
concomitant neuroleptic or antidepressant 
therapy (Buoht and Wahlin 1979) or due to 
the affective illness itself (Coppen et al. 
1974). 
Lithium induced defect in kidney's re-
sponse to ADH has been postulated to ac-
count for nephrogenic diabetes insipidus 
causing polyuria (Cox and Singer 1981, 
Jackson et al. 1980), while a control dia-
betes insipidus due to long term lithium 
therapy has also been proposed (Cox and 
Singer 1981). In the present study patients 
neither had polyuria, nor patients had signi-
ficantly different urine ADH levels. 
Thus in the present study patients on li-
thium therapy upto 1 year did not have any 
deterioration in kidney functions. It should 
be realised however that we have studied 
patients who had received lithium only 
upto one year. What happens to patients N. SETHI ET AL.  71 
who receive lithium for a much longer pe-
riod still needs to be studied. 
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